Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Aug 31, 2025 | (Q4)Aug 31, 2025 | (Q3)May 31, 2025 | (Q2)Feb 28, 2025 | (Q1)Nov 30, 2024 | (FY)Aug 31, 2024 | (Q4)Aug 31, 2024 | (Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -6.38%-588.85K | 66.22%-79.91K | 140.94%42.97K | -1.74%-148.86K | -513.44%-403.05K | 31.41%-553.54K | -333.35%-236.57K | 69.05%-104.95K | 40.32%-146.31K | 79.73%-65.7K |
| Net income from continuing operations | 46.70%-436.85K | 88.56%-57.61K | 14.76%-95.6K | 10.32%-97.44K | -95.68%-186.2K | 23.82%-819.56K | -86.54%-503.6K | 38.92%-112.15K | 76.50%-108.65K | 40.48%-95.16K |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | --2.81K | --0 | --0 | ---- | ---- |
| Remuneration paid in stock | --0 | ---- | ---- | ---- | ---- | 45.50%331.38K | --331.38K | --0 | ---- | ---- |
| Other non cashItems | ---229.71K | ---40.56K | --7.42K | ---75.81K | ---120.76K | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | 213.99%77.71K | 128.39%18.27K | 1,720.21%131.15K | 160.27%24.39K | -426.26%-96.09K | -266.17%-68.17K | -117.33%-64.36K | 104.63%7.21K | -281.69%-40.47K | 117.94%29.45K |
| -Change in receivables | 95.65%-1.18K | -1.43%-42.63K | 4,057.53%83.11K | 1,451.24%81.98K | -1,715.52%-123.64K | -324.61%-27.1K | -207.96%-42.03K | 110.41%2K | -68.17%5.29K | 131.54%7.65K |
| -Change in prepaid assets | 197.72%81.56K | 115.24%11.41K | 34.65%11.41K | 383.85%36.26K | 622.45%22.48K | -1,559.36%-83.46K | -148.41%-74.86K | 106.23%8.47K | 6.90%-12.77K | -632.43%-4.3K |
| -Change in payables and accrued expense | -106.29%-2.66K | -5.78%49.49K | 1,220.78%36.63K | -184.55%-93.85K | -80.59%5.07K | 82.33%42.38K | -70.45%52.53K | -1,110.37%-3.27K | -144.55%-32.98K | 118.54%26.1K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -6.38%-588.85K | 66.22%-79.91K | 140.94%42.97K | -1.74%-148.86K | -513.44%-403.05K | 31.41%-553.54K | -333.35%-236.57K | 69.05%-104.95K | 40.32%-146.31K | 79.73%-65.7K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -472.32%-1.64M | 17.16%-193.72K | 699.54%89.93K | -5,876.28%-896.44K | -2,672.56%-642.38K | 46.01%-287.01K | -15.50%-233.84K | 89.41%-15K | 81.45%-15K | 78.26%-23.17K |
| Net other investing changes | -472.32%-1.64M | 17.16%-193.72K | 699.54%89.93K | -5,876.28%-896.44K | -2,672.56%-642.38K | 46.01%-287.01K | -15.50%-233.84K | 89.41%-15K | 81.45%-15K | 78.26%-23.17K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -472.32%-1.64M | 17.16%-193.72K | 699.54%89.93K | -5,876.28%-896.44K | -2,672.56%-642.38K | 46.01%-287.01K | -15.50%-233.84K | 89.41%-15K | 81.45%-15K | 78.26%-23.17K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 167.18%2.5M | 0 | 0 | 0 | 2.5M | 937.5K | 626.3K | 0 | 311.2K | 0 |
| Net common stock issuance | 189.11%2.73M | --0 | --0 | --0 | --2.73M | --943.5K | --627.5K | --0 | --316K | --0 |
| Net other financing activities | -3,615.72%-222.94K | --0 | --0 | --0 | ---222.94K | ---6K | ---1.2K | --0 | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 167.18%2.5M | --0 | --0 | --0 | --2.5M | --937.5K | --626.3K | --0 | --311.2K | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 57.58%265.35K | 642.11%812.32K | 196.16%679.43K | 2,068.92%1.72M | 57.58%265.35K | -88.83%168.39K | -59.38%109.46K | -69.42%229.41K | -92.61%79.52K | -88.83%168.39K |
| Current changes in cash | 181.93%273.35K | -275.53%-273.63K | 210.80%132.9K | -797.38%-1.05M | 1,742.09%1.46M | 107.24%96.96K | 254.23%155.89K | 75.05%-119.95K | 145.97%149.89K | 79.37%-88.87K |
| End cash Position | 103.01%538.7K | 103.01%538.7K | 642.11%812.32K | 196.16%679.43K | 2,068.92%1.72M | 57.58%265.35K | 57.58%265.35K | -59.38%109.46K | -69.42%229.41K | -92.61%79.52K |
| Free cash from | -6.38%-588.85K | 66.22%-79.91K | 140.94%42.97K | -1.74%-148.86K | -513.44%-403.05K | 31.41%-553.54K | -333.35%-236.57K | 69.05%-104.95K | 40.32%-146.31K | 79.73%-65.7K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.